Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat.

Neuroscience·2010
Same author

Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

American journal of physiology. Heart and circulatory physiology·2005
Same author

Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.

American journal of physiology. Heart and circulatory physiology·2002
Same author

Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability.

Peptides·2002
Same author

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.

Trends in neurosciences·2001
Same author

Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.

The Journal of pharmacology and experimental therapeutics·2001

Related Experiment Video

Updated: Jul 3, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Diabetes, cognitive function, and the blood-brain barrier.

J D Huber1

  • 1Department of Basic Pharmaceutical Sciences, West Virginia University, Morgantown, WV 26506, USA. jhuber@hsc.wvu.edu

Current Pharmaceutical Design
|August 5, 2008
PubMed
Summary

Diabetes mellitus significantly impacts blood vessels, increasing risks for cardiovascular and cerebrovascular diseases. This review explores how diabetes affects the brain

Area of Science:

  • Neuroscience
  • Endocrinology
  • Vascular Biology

Background:

  • Diabetes mellitus is a systemic disease impacting vasculature, increasing risks for cardiovascular and cerebrovascular conditions.
  • Both large and small blood vessels are affected, with microangiopathy (small vessel dysfunction) driving diabetes-related disabilities.
  • Increased incidences of vascular dementia and potential links to Alzheimer's disease are noted in diabetic individuals.

Purpose of the Study:

  • To review the relationship between diabetes mellitus and cognitive changes.
  • To focus on the role of cerebral microvascular alterations and blood-brain barrier dysfunction in cognitive decline.

Main Methods:

  • Literature review of clinical evidence and scientific communications.
  • Analysis of the impact of diabetes on cerebral microvasculature.

More Related Videos

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
09:10

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

Published on: January 12, 2024

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
06:19

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jul 3, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
09:10

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

Published on: January 12, 2024

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
06:19

Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease

Published on: October 20, 2023

  • Examination of blood-brain barrier structure and function in the context of diabetes.
  • Main Results:

    • Diabetes mellitus affects both macrovascular and microvascular systems.
    • Endothelial dysfunction in microangiopathy is a key factor in diabetes complications.
    • Cerebral microvascular changes and blood-brain barrier alterations are implicated in cognitive impairment in diabetics.

    Conclusions:

    • Diabetes mellitus poses significant risks to cerebral microvasculature.
    • Alterations in blood-brain barrier structure and function may contribute to long-term cognitive decline in diabetes.
    • Further research is needed to fully understand the impact of diabetes on the brain.